ABBV vs. PFE
Compare and contrast key facts about AbbVie Inc. (ABBV) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or PFE.
Correlation
The correlation between ABBV and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABBV vs. PFE - Performance Comparison
Key characteristics
ABBV:
0.73
PFE:
-0.62
ABBV:
0.99
PFE:
-0.58
ABBV:
1.15
PFE:
0.93
ABBV:
0.88
PFE:
-0.21
ABBV:
2.15
PFE:
-0.91
ABBV:
8.44%
PFE:
13.28%
ABBV:
27.49%
PFE:
23.81%
ABBV:
-45.09%
PFE:
-58.96%
ABBV:
-13.55%
PFE:
-56.34%
Fundamentals
ABBV:
$351.09B
PFE:
$134.92B
ABBV:
$2.34
PFE:
$1.41
ABBV:
84.82
PFE:
16.87
ABBV:
0.42
PFE:
0.61
ABBV:
6.05
PFE:
2.17
ABBV:
105.59
PFE:
1.56
ABBV:
$57.37B
PFE:
$62.46B
ABBV:
$44.44B
PFE:
$42.09B
ABBV:
$16.33B
PFE:
$16.71B
Returns By Period
In the year-to-date period, ABBV achieves a 6.39% return, which is significantly higher than PFE's -11.99% return. Over the past 10 years, ABBV has outperformed PFE with an annualized return of 15.79%, while PFE has yielded a comparatively lower 0.57% annualized return.
ABBV
6.39%
6.62%
-5.71%
19.87%
22.17%
15.79%
PFE
-11.99%
5.17%
-13.65%
-13.66%
-4.28%
0.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. PFE — Risk-Adjusted Performance Rank
ABBV
PFE
ABBV vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABBV vs. PFE - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.44%, less than PFE's 9.23% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
PFE Pfizer Inc. | 9.23% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
Drawdowns
ABBV vs. PFE - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum PFE drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for ABBV and PFE. For additional features, visit the drawdowns tool.
Volatility
ABBV vs. PFE - Volatility Comparison
AbbVie Inc. (ABBV) has a higher volatility of 9.87% compared to Pfizer Inc. (PFE) at 8.97%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABBV vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. PFE - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.